These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 38242443)

  • 21. Hematopoietic Cell Transplantation-Comorbidity Index Score Is Correlated with Treatment-Related Mortality and Overall Survival following Second Allogeneic Hematopoietic Cell Transplantation in Children.
    Forlanini F; Zinter MS; Dvorak CC; Bailey-Olson M; Winestone LE; Shimano KA; Higham CS; Melton A; Chu J; Kharbanda S
    Transplant Cell Ther; 2022 Mar; 28(3):155.e1-155.e8. PubMed ID: 34848362
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chronic Graft-versus-Host Disease, Nonrelapse Mortality, and Disease Relapse in Older versus Younger Adults Undergoing Matched Allogeneic Peripheral Blood Hematopoietic Cell Transplantation: A Center for International Blood and Marrow Transplant Research Analysis.
    Bhatt VR; Wang T; Chen K; Kitko CL; MacMillan ML; Pidala JA; Al Malki MM; Badawy SM; Beitinjaneh A; Ganguly S; Hamilton B; Hildebrandt GC; Lekakis LJ; Liu H; Maziarz RT; Modi D; Murthy HS; Preussler JM; Sharma A; Spellman SR; Arora M; Lee SJ
    Transplant Cell Ther; 2022 Jan; 28(1):34-42. PubMed ID: 34637965
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of pre-existing comorbidities with outcome of allogeneic hematopoietic cell transplantation. A retrospective analysis from the EBMT.
    Penack O; Peczynski C; Mohty M; Yakoub-Agha I; de la Camara R; Glass B; Duarte RF; Kröger N; Schoemans H; Koenecke C; Peric Z; Basak GW
    Bone Marrow Transplant; 2022 Feb; 57(2):183-190. PubMed ID: 34718346
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Validation of the Hematopoietic Cell Transplantation-Specific Comorbidity Index in Nonmyeloablative Allogeneic Stem Cell Transplantation.
    Veeraputhiran M; Yang L; Sundaram V; Arai S; Lowsky R; Miklos D; Meyer E; Muffly L; Negrin R; Rezvani A; Shizuru J; Weng WK; Johnston L
    Biol Blood Marrow Transplant; 2017 Oct; 23(10):1744-1748. PubMed ID: 28668491
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dynamic EASIX scores closely predict nonrelapse mortality after allogeneic hematopoietic cell transplantation.
    Nawas MT; Sanchez-Escamilla M; Devlin SM; Maloy MA; Ruiz JD; Sauter CS; Giralt SA; Perales MA; Scordo M
    Blood Adv; 2022 Nov; 6(22):5898-5907. PubMed ID: 35977079
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypertension and diabetes mellitus in adult and pediatric survivors of allogeneic hematopoietic cell transplantation.
    Majhail NS; Challa TR; Mulrooney DA; Baker KS; Burns LJ
    Biol Blood Marrow Transplant; 2009 Sep; 15(9):1100-7. PubMed ID: 19660723
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fractionated Infusion of Hematopoietic Progenitor Cells Does Not Improve Neutrophil Recovery or Survival in Allograft Recipients.
    Tamari R; Brown S; Devlin SM; Kosuri S; Maloy MA; Ponce DM; Sauter C; Shaffer B; Dahi P; Young JW; Jakubowski A; Papadopoulos EB; Castro-Malaspina H; Perales MA; Giralt SA; Gyurkocza B
    Transplant Cell Ther; 2021 Oct; 27(10):852.e1-852.e9. PubMed ID: 34214736
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Blood glucose control using a computer-guided glucose management system in allogeneic hematopoietic cell transplant recipients.
    Espina C; Jenkins I; Taylor L; Farah R; Cho E; Epworth J; Coleman K; Pinelli J; Mentzer S; Jarrett L; Gooley T; O'Donnell P; Hirsch IB; Bar M
    Bone Marrow Transplant; 2016 Jul; 51(7):973-9. PubMed ID: 27042836
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Baseline Renal Function and Albumin are Powerful Predictors for Allogeneic Transplantation-Related Mortality.
    Shouval R; de Jong CN; Fein J; Broers AEC; Danylesko I; Shimoni A; Reurs MR; Baars AE; van der Schaft N; Nagler A; Cornelissen JJ
    Biol Blood Marrow Transplant; 2018 Aug; 24(8):1685-1691. PubMed ID: 29753163
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Planned Granulocyte Colony-Stimulating Factor Adversely Impacts Survival after Allogeneic Hematopoietic Cell Transplantation Performed with Thymoglobulin for Myeloid Malignancy.
    Orfali N; Zhang MJ; Allbee-Johnson M; Boelens JJ; Artz AS; Brunstein CG; McNiece IK; Milano F; Abid MB; Chee L; Diaz MA; Grunwald MR; Hematti P; Hsu J; Lazarus HM; Munshi PN; Prestidge T; Ringden O; Rizzieri D; Riches ML; Seo S; Solh M; Solomon S; Szwajcer D; Yared J; van Besien K; Eapen M
    Transplant Cell Ther; 2021 Dec; 27(12):993.e1-993.e8. PubMed ID: 34507002
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of pre-transplant depression on outcomes of allogeneic and autologous hematopoietic stem cell transplantation.
    El-Jawahri A; Chen YB; Brazauskas R; He N; Lee SJ; Knight JM; Majhail N; Buchbinder D; Schears RM; Wirk BM; Wood WA; Ahmed I; Aljurf M; Szer J; Beattie SM; Battiwalla M; Dandoy C; Diaz MA; D'Souza A; Freytes CO; Gajewski J; Gergis U; Hashmi SK; Jakubowski A; Kamble RT; Kindwall-Keller T; Lazarus HM; Malone AK; Marks DI; Meehan K; Savani BN; Olsson RF; Rizzieri D; Steinberg A; Speckhart D; Szwajcer D; Schoemans H; Seo S; Ustun C; Atsuta Y; Dalal J; Sales-Bonfim C; Khera N; Hahn T; Saber W
    Cancer; 2017 May; 123(10):1828-1838. PubMed ID: 28102896
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic Performance of the Augmented Hematopoietic Cell Transplantation-Specific Comorbidity/Age Index in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation from Alternative Graft Sources.
    Elsawy M; Storer BE; Milano F; Sandmaier BM; Delaney C; Salit RB; Rashad AH; Woolfrey AE; Appelbaum FR; Storb R; Sorror ML
    Biol Blood Marrow Transplant; 2019 May; 25(5):1045-1052. PubMed ID: 30500442
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypoalbuminemia at Day +90 Is Associated with Inferior Nonrelapse Mortality and Overall Survival in Allogeneic Hematopoietic Cell Transplantation Recipients: A Confirmatory Study.
    Murthy HS; Sheets K; Kumar A; Nishihori T; Mina A; Chavez JC; Ayala E; Field T; Mathews J; Locke F; Perez L; Betts BC; Khimani F; Miladinovic B; Tsalatsanis A; Ochoa-Bayona JL; Alsina M; Fernandez H; Pidala J; Anasetti C; Kharfan-Dabaja MA
    Biol Blood Marrow Transplant; 2018 Feb; 24(2):400-405. PubMed ID: 29032266
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preconditioning Frailty Phenotype Influences Survival and Relapse for Older Allogeneic Transplantation Recipients.
    Sung AD; Koll T; Gier SH; Racioppi A; White G; Lew M; Free M; Agarwal P; Bohannon LM; Johnson EJ; Selvan B; Babushok DV; Frey NV; Gill SI; Hexner EO; Martin M; Perl AE; Pratz KW; Luger SM; Chao NJ; Fisher AL; Stadtmauer EA; Porter DL; Loren AW; Bhatt VR; Gimotty PA; McCurdy SR
    Transplant Cell Ther; 2024 Apr; 30(4):415.e1-415.e16. PubMed ID: 38242440
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hematopoietic Cell Transplantation Comorbidity Index Predicts Outcomes in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndromes Receiving CD34
    Barba P; Ratan R; Cho C; Ceberio I; Hilden P; Devlin SM; Maloy MA; Barker JN; Castro-Malaspina H; Jakubowski AA; Koehne G; Papadopoulos EB; Ponce DM; Sauter C; Tamari R; van den Brink MRM; Young JW; O'Reilly RJ; Giralt SA; Perales MA
    Biol Blood Marrow Transplant; 2017 Jan; 23(1):67-74. PubMed ID: 27789361
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Promising Outcome of Umbilical Cord Blood Transplantation in Patients with Multiple Comorbidities.
    Adachi Y; Ukai S; Sagou K; Fukushima N; Ozeki K; Kohno A
    Biol Blood Marrow Transplant; 2018 Jul; 24(7):1455-1462. PubMed ID: 29476952
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Malglycemia is associated with poor outcomes in pediatric and adolescent hematopoietic stem cell transplant patients.
    Sopfe J; Pyle L; Keating AK; Campbell K; Liu AK; Wadwa RP; Verneris MR; Giller RH; Forlenza GP
    Blood Adv; 2019 Feb; 3(3):350-359. PubMed ID: 30718242
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Autologous transplantation versus allogeneic transplantation in patients with follicular lymphoma experiencing early treatment failure.
    Smith SM; Godfrey J; Ahn KW; DiGilio A; Ahmed S; Agrawal V; Bachanova V; Bacher U; Bashey A; Bolaños-Meade J; Cairo M; Chen A; Chhabra S; Copelan E; Dahi PB; Aljurf M; Farooq U; Ganguly S; Hertzberg M; Holmberg L; Inwards D; Kanate AS; Karmali R; Kenkre VP; Kharfan-Dabaja MA; Klein A; Lazarus HM; Mei M; Mussetti A; Nishihori T; Ramakrishnan Geethakumari P; Saad A; Savani BN; Schouten HC; Shah N; Urbano-Ispizua A; Vij R; Vose J; Sureda A; Hamadani M
    Cancer; 2018 Jun; 124(12):2541-2551. PubMed ID: 29645093
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of Risk Scoring Systems in HLA-Matched Related Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Cohort Study.
    Aladağ E; Demiroğlu H; Büyükaşık Y; Göker H
    Turk J Haematol; 2021 Jun; 38(2):138-144. PubMed ID: 32539316
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Graft Cryopreservation Does Not Impact Overall Survival after Allogeneic Hematopoietic Cell Transplantation Using Post-Transplantation Cyclophosphamide for Graft-versus-Host Disease Prophylaxis.
    Hamadani M; Zhang MJ; Tang XY; Fei M; Brunstein C; Chhabra S; D'Souza A; Milano F; Phelan R; Saber W; Shaw BE; Weisdorf D; Devine SM; Horowitz MM
    Biol Blood Marrow Transplant; 2020 Jul; 26(7):1312-1317. PubMed ID: 32283185
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.